Positive hits from your high-throughput screen are promising, but it’s not worth proceeding down the drug development pathway without evaluating your compound’s characteristics first. To ensure the fastest and least expensive journey of your compound to preclinical nomination, consult with Charles River drug discovery chemists and biologists early. Their integrated approach to designing, synthesizing, and optimizing compounds efficiently advances your therapeutic drug.
Eliminate complicated logistics, increased administrative costs, and cycle time slippage by contracting with a preclinical drug discovery CRO that manages your project from drug target discovery to hit identification, hit-to-lead, and lead optimization. Charles River offers these services:
DMPK ADME Studies: